RecruitingNCT02432625

BBD Longitudinal Study of Osteogenesis Imperfecta

Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta


Sponsor

Baylor College of Medicine

Enrollment

1,000 participants

Start Date

Jun 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life. The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with osteogenesis imperfecta. The study is currently recruiting participants at 12 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(12)

Phoenix Children's Hospital

Phoenix, Arizona, United States

University of California Los Angeles

Los Angeles, California, United States

AI Dupont Hospital for Children

Wilmington, Delaware, United States

Children's National Medical Center

Washington D.C., District of Columbia, United States

University of South Florida

Tampa, Florida, United States

Kennedy Krieger Institute / Hugo W. Moser Research Institute

Baltimore, Maryland, United States

University of Nebraska Medical Center

Omaha, Nebraska, United States

Hospital for Special Surgery

New York, New York, United States

Oregon Health and Science University

Portland, Oregon, United States

Baylor College of Medicine

Houston, Texas, United States

Shriners Hospital for Children, Chicago / Marquette University

Milwaukee, Wisconsin, United States

Shriners Hospital for Children

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02432625


Related Trials